Since March 2020 Arcadia is partnering with Biotechne to provide services for immuno-assay testing and development supplying you with ELLA Next Generation ELISA technology.
ELLA enables the detection of biomarkers in single and multiplex formats in a microfluidic setup. Ella’s combination of performance and workflow brings immunoassays to the next level delivering data with sub-picogram level sensitivity, 4+ logs of dynamic range and reproducibility that rivals the best laboratory automation. Ella’s assays support single or multianalyte experiments with no crossreactivity, and getting good immunoassay reproducibility. Ella provides the analytical power for your research with a high level of automation and validation in a wide variety of application fields like Cancer, Neurology and Cell Therapy.
Biomarker discovery and validation experiments can be executed on multiple types of samples ranging from serum and plasma to CSF.